Key Points The transaction involved shares equal to 13% of the stake held before the filing. The disposition was a direct sell of common stock, and the reporting person retains no indirect equity holdings. The sale was executed under a Rule 10b5-1 trading plan adopted by the executive on June 1, 2026. 10 stocks we like better than ICU Medical › Chief Financial Officer Brian Michael Bonnell executed a sale of 9,307 shares of ICU Medical (NASDAQ:ICUI) on Aug. 31, 2026, according to a recent SEC Form 4 filing . Transaction summary Transaction value based on SEC Form 4 weighted average sale price ($172.79); post-transaction value based on Aug. 31, 2026, market close ($172.95). Key questions What was the nature of the execution?
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.